Juno Pharmaceuticals South Africa is pleased to announce that it has acquired a minority stake in Trinity Pharma in partnership with India-based Strides Pharma, which purchased a majority stake in the rapidly-growing South African retail pharmaceutical company effective December 2017.
The Juno team is excited to partner with both Trinity’s existing management team – which is staying on as a minority partner following the transaction – and the Strides group as they collectively work to build on Trinity’s already robust sales base and product pipeline. With our collective efforts and investment, Trinity stands poised to establish itself as a leader in the South African pharmaceutical space over the next decade and beyond.